Tinidazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 300 mg, 500 mg, 1 gm
Reference Brands: Tindamax (USA), Fasigyn (USA/EU),
Category:
Anthelmintic
Tinidazole is used to treat infections caused by protozoa (eg, trichomoniasis, giardiasis, and amebiasis). It is also used to treat adult women with vaginal infections (bacterial vaginosis). Tinidazole belongs to the group of medicines called antiprotozoals.
Tinidazole Tablets is available in Tablets
and strengths such as 300 mg, 500 mg, 1 gm.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tinidazole Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tinidazole Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tinidazole, marketed under the brand name Tindamax and others, is an antiprotozoal and antibacterial medication primarily used to treat infections caused by certain anaerobic bacteria and protozoa. It is highly effective against protozoal infections such as amebiasis, giardiasis, and trichomoniasis. As a member of the nitroimidazole class, Tinidazole works by disrupting the DNA synthesis of susceptible microorganisms, leading to their death and resolution of infection.
Developed in 1972, Tinidazole has become a key option for treating gastrointestinal and genitourinary infections caused by protozoa. In addition to its established uses, it is currently being evaluated for the treatment of Helicobacter pylori infections, particularly in patients with low-grade gastric lymphoma, reflecting its broader potential in managing bacterial-related conditions. Tinidazole is typically administered orally and is valued for its effectiveness, convenient dosing, and well-tolerated safety profile. Proper use requires adherence to prescribed dosing regimens to ensure complete eradication of the infection and to prevent resistance. Its role in modern antimicrobial therapy underscores its continued importance in the management of protozoal and anaerobic bacterial infections worldwide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing